Innovations in Cancer Winter 2022
Showing of 4 results
UH Seidman Cancer Center to Launch First-Ever Trial of NK Therapy and Vactosertib in Treating Colorectal Cancer and Hematological Malignancies
Trial employs new method of expanding and activating universal donor NK cells developed in Cleveland - Innovations in Cancer | Winter 2022
Expanded Neuroendocrine Tumor Team at UH Seidman Cancer Center Boosts Access to Clinical Trials
Trials of promising anti-angiogenesis therapies under way here - Innovations in Cancer | Winter 2022
Researchers Show Increased Survival Rate in Prostate Cancer Patients with Addition of Hormone Therapy Treatments
First-of-its-kind meta-analysis published in The Lancet Oncology - Innovations in Cancer Winter 2022
Team Led by UH Seidman Cancer Center Researcher Develops and Validates Three-in-One CAR T Therapy
Approach detailed in the journal Nature Communications shows therapeutic potential of BAFF CAR T for treating multiple B cell cancers, using mouse models with high effectiveness and minimum side effects - Innovations in Cancer | Winter 2022
Results are loading...